Published in Med Clin North Am on March 01, 1982
Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J Clin Invest (1987) 1.56
Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J (1989) 1.11
Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A (1984) 1.03
Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest (1986) 0.99
Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes. J Clin Invest (1988) 0.98
Structural relationship of human apolipoprotein B48 to apolipoprotein B100. J Clin Invest (1987) 0.93
Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis. J Clin Invest (1985) 0.92
Apolipoprotein B detected in the plasma of a patient with homozygous hypobetalipoproteinaemia: implications for aetiology. J Med Genet (1983) 0.91
A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia. J Clin Invest (1991) 0.84
Segregation analysis of low levels of high-density lipoprotein cholesterol in the collaborative Lipid Research Clinics Program Family Study. Am J Hum Genet (1987) 0.83
Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia. J Neurol Neurosurg Psychiatry (1997) 0.81
A major gene for primary hypoalphalipoproteinemia. Am J Hum Genet (1986) 0.81
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet (2008) 5.85
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A (1980) 2.88
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA (1990) 2.78
Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem (1997) 2.53
Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med (1994) 2.49
Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol (1983) 2.33
Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest (1973) 2.26
A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Anal Biochem (1973) 2.19
Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest (1975) 2.18
Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest (1970) 2.17
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J Lipid Res (2001) 2.02
Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia. Arteriosclerosis (1983) 1.90
Isolation of a cDNA clone encoding the amino-terminal region of human apolipoprotein B. Proc Natl Acad Sci U S A (1986) 1.86
Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res (1977) 1.80
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A (1973) 1.66
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol (1998) 1.55
Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J Clin Invest (1980) 1.54
Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol (1977) 1.53
Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science (1971) 1.51
Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest (1981) 1.50
Analysis of cDNA clones encoding the entire B-26 region of human apolipoprotein B. Proc Natl Acad Sci U S A (1986) 1.48
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb (1994) 1.42
Metabolism of apoprotein B of plasma very low density lipoproteins in the rat. J Clin Invest (1975) 1.36
Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A (1984) 1.36
Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest (1993) 1.36
Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins. Proc Natl Acad Sci U S A (1982) 1.35
Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J Lipid Res (1982) 1.35
Effective patient care in the pediatric ambulatory setting: a study of the acute care clinic. Pediatrics (1969) 1.32
Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum. Proc Natl Acad Sci U S A (1979) 1.31
Dispensing errors and counseling in community practice. Am Pharm (1995) 1.26
Fatty acid binding protein. Isolation from rat liver, characterization, and immunochemical quantification. J Biol Chem (1982) 1.26
Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation (1995) 1.26
Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma. J Clin Invest (1983) 1.25
Subunit heterogeneity in human serum beta lipoprotein. Proc Natl Acad Sci U S A (1970) 1.25
Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I. Proc Natl Acad Sci U S A (1984) 1.23
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res (2000) 1.23
Chylomicrons can inhibit endotoxin activity in vitro. J Surg Res (1991) 1.18
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest (1995) 1.17
Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci U S A (1983) 1.16
Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proc Natl Acad Sci U S A (1977) 1.16
Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. N Engl J Med (1981) 1.16
Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci U S A (1992) 1.14
Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption. Biochemistry (1994) 1.13
Relation of plasma lipid and apoprotein levels to progressive intimal hyperplasia after arterial endarterectomy. Circulation (1992) 1.12
Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med (1995) 1.09
Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3. J Clin Invest (1983) 1.09
Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J Lipid Res (1985) 1.09
Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis (1983) 1.08
A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med (2001) 1.06
Drugs and lipid metabolism. Annu Rev Pharmacol (1973) 1.05
Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation (1997) 1.02
Cryo-electron microscopy of low density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moiety. J Lipid Res (1997) 1.01
A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med (1998) 1.01
The effect of ligand heterogeneity on the Scatchard plot. Particular relevance to lipoprotein binding analysis. J Biol Chem (1985) 1.00
Niacin--the long and the short of it. West J Med (1991) 0.98
Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia. J Clin Invest (1986) 0.97
Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis (1981) 0.97
Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender. J Lipid Res (1998) 0.97
Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma. Biochem Med (1979) 0.96
Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables. Am J Epidemiol (1982) 0.96
Detection of endotoxin in triglyceride-rich lipoproteins in vitro. J Lab Clin Med (1991) 0.96
Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol (1996) 0.96
The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J (1993) 0.95
Mechanism of the hypolipemic effect of clofibrate in postabsorptive man. J Clin Invest (1973) 0.93
Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br J Ophthalmol (2009) 0.93
Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Ann Intern Med (1987) 0.92
Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J Clin Invest (1988) 0.92
Structural domains of human apolipoprotein B-100. Differential accessibility to limited proteolysis of B-100 in low density and very low density lipoproteins. J Biol Chem (1989) 0.92
A variant primary structure of apolipoprotein C-II in individuals of African descent. J Clin Invest (1986) 0.91
Splanchnic metabolism in von Gierke's disease (glycogenosis type I). Trans Assoc Am Physicians (1969) 0.91
Stability of the apoprotein of human serum low density lipoprotein: absence of endogenous endopeptidase activity. Biochem Biophys Res Commun (1975) 0.90
Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. J Clin Invest (1991) 0.90
Chylomicrons enhance endotoxin excretion in bile. Infect Immun (1993) 0.90
The complement system in cryoglobulinaemia. Interaction with immunoglobulins and lipoproteins. Clin Exp Immunol (1975) 0.90
Analysis of hABC1 gene 5' end: additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun (2000) 0.90
Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. J Lipid Res (2000) 0.89
Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol Oncol (1999) 0.89
Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity. J Lipid Res (1991) 0.89
The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds. J Lipid Res (1999) 0.88